Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 2/3 1Phase 1 1

Status

Completed 161Terminated 30Unknown 29Active not recruiting 18Withdrawn 14Recruiting 9Not yet recruiting 6

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 20Thoracic 17Breast 13Head & Neck 12Genitourinary 12CNS 9Lymphoid 6Gynecologic 6Tumor-Agnostic 4Sarcoma 2Other hematologic neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Lymphoma, Non-Hodgkin 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Lymphoma 1Hodgkin Disease 1

Interventions

Cyclophosphamide 32Rituximab 24zanubrutinib 19Vincristine 16fludarabine 14Prednisone 14Magnetic Resonance Spectroscopy 14venetoclax 13blinatumomab 13Specimen Handling 13Doxorubicin 13Bendamustine Hydrochloride 11obinutuzumab 10Lenalidomide 9Dexamethasone 9polatuzumab vedotin 8Methotrexate 8Biopsy 8glofitamab 7Prednisolone 7Cytarabine 7Radiotherapy 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6pirtobrutinib 5pegaspargase 5Immunotherapy, Adoptive 5tislelizumab 4tafasitamab 4selinexor 4orelabrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Not yet recruiting × Radiotherapy × Lymphoid × Clear all
NCT07478848 2026-05-22

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Abramson Cancer Center at Penn Medicine

Phase 1 Not yet recruiting
14 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07517705 2026-05-13

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

University of Nebraska

Phase 2 Not yet recruiting
50 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07554482 2026-04-28

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

Beijing Tongren Hospital

Phase 2 Not yet recruiting
34 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT07072585 2025-12-31

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Children's Oncology Group

Phase 2/3 Not yet recruiting
1,708 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06646666 2024-11-01

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Ruijin Hospital

Phase 2 Not yet recruiting
35 enrolled
Lymphoid

Lymphoma, B-Cell

NCT05627115 2023-11-29

RATiFY

University College, London

Phase 2 Not yet recruiting
80 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡